Cargando…
The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
Objective: Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well cha...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288228/ https://www.ncbi.nlm.nih.gov/pubmed/25541931 http://dx.doi.org/10.4274/mirt.33042 |
_version_ | 1782351935605571584 |
---|---|
author | Kaçar Güveli, Tülay Özkan, Sezer Öner Tamam, Müge Uyanık, Ercan Ediz, Nurcan Mülazımoğlu, Mehmet Özpaçacı, Tevfik |
author_facet | Kaçar Güveli, Tülay Özkan, Sezer Öner Tamam, Müge Uyanık, Ercan Ediz, Nurcan Mülazımoğlu, Mehmet Özpaçacı, Tevfik |
author_sort | Kaçar Güveli, Tülay |
collection | PubMed |
description | Objective: Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well characterized. The aim of this study was to evaluate the extent of retinal damage among patients who had received high doses of radioiodine treatment. Methods: Forty eyes of 20 patients (3 male, 17 female) who received 250-1000 mCi during 131I therapy and on ophthalmological follow up for a year after the last treatment were included in the study. Mean age of the study group was 50 years (range 25-70 years). In ophthalmologic examination, visual acuity was measured in order to determine visual loss. Intraocular pressure was measured in all the patients. Then lens examination was carried out with slit lamp biomicroscopy in order to investigate cataract or partial lens opacities. Fundus observation was carried out through the dilated pupil with slit lamp biomicroscopy using 90 D noncontact lens. Result: The best corrected visual aquity with Snellen chart was found as 1.0 in 36 eyes (90%) and between 0.6 and 0.9 (10%) in 4 eyes (10%). At the biomicroscopic fundus examination, retinal hemorrhage consistent with radiation retinopathy, microaneurysm, microinfarction, edema or exudation, vitreus hemorrhage, partial or total optical disc pallor indicating papillopathy in the optic disc were not observed in any of the eyes. Conclusion: This result indicates that there is not any significant correlation between repeated high-dose radioiodine therapy and radiation retinopathy in differentiated thyroid carcinomas. Even though there is not a significant restriction in use of higher doses of radioiodine therapy in differentiated thyroid carcinoma, more extensive studies are needed in order to obtain more accurate data on possible occurrence of retinopathy. |
format | Online Article Text |
id | pubmed-4288228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-42882282015-01-21 The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment Kaçar Güveli, Tülay Özkan, Sezer Öner Tamam, Müge Uyanık, Ercan Ediz, Nurcan Mülazımoğlu, Mehmet Özpaçacı, Tevfik Mol Imaging Radionucl Ther Original Article Objective: Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well characterized. The aim of this study was to evaluate the extent of retinal damage among patients who had received high doses of radioiodine treatment. Methods: Forty eyes of 20 patients (3 male, 17 female) who received 250-1000 mCi during 131I therapy and on ophthalmological follow up for a year after the last treatment were included in the study. Mean age of the study group was 50 years (range 25-70 years). In ophthalmologic examination, visual acuity was measured in order to determine visual loss. Intraocular pressure was measured in all the patients. Then lens examination was carried out with slit lamp biomicroscopy in order to investigate cataract or partial lens opacities. Fundus observation was carried out through the dilated pupil with slit lamp biomicroscopy using 90 D noncontact lens. Result: The best corrected visual aquity with Snellen chart was found as 1.0 in 36 eyes (90%) and between 0.6 and 0.9 (10%) in 4 eyes (10%). At the biomicroscopic fundus examination, retinal hemorrhage consistent with radiation retinopathy, microaneurysm, microinfarction, edema or exudation, vitreus hemorrhage, partial or total optical disc pallor indicating papillopathy in the optic disc were not observed in any of the eyes. Conclusion: This result indicates that there is not any significant correlation between repeated high-dose radioiodine therapy and radiation retinopathy in differentiated thyroid carcinomas. Even though there is not a significant restriction in use of higher doses of radioiodine therapy in differentiated thyroid carcinoma, more extensive studies are needed in order to obtain more accurate data on possible occurrence of retinopathy. Galenos Publishing 2014-10 2014-10-05 /pmc/articles/PMC4288228/ /pubmed/25541931 http://dx.doi.org/10.4274/mirt.33042 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kaçar Güveli, Tülay Özkan, Sezer Öner Tamam, Müge Uyanık, Ercan Ediz, Nurcan Mülazımoğlu, Mehmet Özpaçacı, Tevfik The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment |
title | The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment |
title_full | The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment |
title_fullStr | The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment |
title_full_unstemmed | The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment |
title_short | The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment |
title_sort | effect of high dose radioiodine therapy on formation of radiation retinopathy during thyroid cancer treatment |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288228/ https://www.ncbi.nlm.nih.gov/pubmed/25541931 http://dx.doi.org/10.4274/mirt.33042 |
work_keys_str_mv | AT kacarguvelitulay theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT ozkansezer theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT onertamammuge theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT uyanıkercan theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT ediznurcan theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT mulazımoglumehmet theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT ozpacacıtevfik theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT kacarguvelitulay effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT ozkansezer effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT onertamammuge effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT uyanıkercan effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT ediznurcan effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT mulazımoglumehmet effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment AT ozpacacıtevfik effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment |